Product NDC: | 43547-253 |
Proprietary Name: | Chlordiazepoxide Hydrochloride |
Non Proprietary Name: | Chlordiazepoxide Hydrochloride |
Active Ingredient(s): | 25 mg/1 & nbsp; Chlordiazepoxide Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, GELATIN COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43547-253 |
Labeler Name: | Solco Healthcare US LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA085475 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100515 |
Package NDC: | 43547-253-10 |
Package Description: | 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (43547-253-10) |
NDC Code | 43547-253-10 |
Proprietary Name | Chlordiazepoxide Hydrochloride |
Package Description | 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (43547-253-10) |
Product NDC | 43547-253 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlordiazepoxide Hydrochloride |
Dosage Form Name | CAPSULE, GELATIN COATED |
Route Name | ORAL |
Start Marketing Date | 20100515 |
Marketing Category Name | ANDA |
Labeler Name | Solco Healthcare US LLC |
Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |